211 related articles for article (PubMed ID: 17344365)
1. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.
O'Neill AJ; Larsen AR; Skov R; Henriksen AS; Chopra I
J Clin Microbiol; 2007 May; 45(5):1505-10. PubMed ID: 17344365
[TBL] [Abstract][Full Text] [Related]
2. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
[TBL] [Abstract][Full Text] [Related]
3. Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of
Yin N; Michel C; Makki N; Deplano A; Milis A; Prevost B; Miendje-Deyi VY; Hallin M; Martiny D
Euro Surveill; 2024 May; 29(19):. PubMed ID: 38726693
[TBL] [Abstract][Full Text] [Related]
4. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
Scand J Infect Dis; 2014 Dec; 46(12):832-7. PubMed ID: 25229166
[TBL] [Abstract][Full Text] [Related]
5. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
J Antimicrob Chemother; 2011 Jun; 66(6):1360-4. PubMed ID: 21393202
[TBL] [Abstract][Full Text] [Related]
6. Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.
Deplano A; Hallin M; Bustos Sierra N; Michel C; Prevost B; Martiny D; Yin N
J Antimicrob Chemother; 2023 Aug; 78(8):2061-2065. PubMed ID: 37358399
[TBL] [Abstract][Full Text] [Related]
7. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
O'Neill AJ; Larsen AR; Henriksen AS; Chopra I
Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136
[TBL] [Abstract][Full Text] [Related]
8. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
Laurent F; Tristan A; Croze M; Bes M; Meugnier H; Lina G; Vandenesch F; Etienne J
J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362
[No Abstract] [Full Text] [Related]
9. Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.
Doudoulakakis A; Spiliopoulou I; Spyridis N; Giormezis N; Kopsidas J; Militsopoulou M; Lebessi E; Tsolia M
J Clin Microbiol; 2017 Aug; 55(8):2529-2537. PubMed ID: 28592549
[TBL] [Abstract][Full Text] [Related]
10. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections.
Larsen AR; Skov RL; Jarlier V; Henriksen AS
J Antimicrob Chemother; 2008 Mar; 61(3):589-94. PubMed ID: 18222948
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus.
O'Neill AJ; Chopra I
Mol Microbiol; 2006 Jan; 59(2):664-76. PubMed ID: 16390458
[TBL] [Abstract][Full Text] [Related]
13. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci.
Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M
J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340
[TBL] [Abstract][Full Text] [Related]
14. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
Chen HJ; Hung WC; Tseng SP; Tsai JC; Hsueh PR; Teng LJ
Antimicrob Agents Chemother; 2010 Dec; 54(12):4985-91. PubMed ID: 20855746
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
[TBL] [Abstract][Full Text] [Related]
16. Genetic basis of resistance to fusidic acid in staphylococci.
O'Neill AJ; McLaws F; Kahlmeter G; Henriksen AS; Chopra I
Antimicrob Agents Chemother; 2007 May; 51(5):1737-40. PubMed ID: 17325218
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of fusB in Staphylococcus aureus clinical isolates.
Huang J; Ye M; Ding H; Guo Q; Ding B; Wang M
J Med Microbiol; 2013 Aug; 62(Pt 8):1199-1203. PubMed ID: 23639984
[TBL] [Abstract][Full Text] [Related]
18. New structure of phage-related islands carrying fusB and a virulence gene in fusidic acid-resistant Staphylococcus epidermidis.
Chen HJ; Chang YC; Tsai JC; Hung WC; Lin YT; You SJ; Tseng SP; Teng LJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5737-9. PubMed ID: 23979742
[TBL] [Abstract][Full Text] [Related]
19. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway.
Tveten Y; Jenkins A; Kristiansen BE
J Antimicrob Chemother; 2002 Dec; 50(6):873-6. PubMed ID: 12461006
[TBL] [Abstract][Full Text] [Related]
20. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41.
Koning S; van Belkum A; Snijders S; van Leeuwen W; Verbrugh H; Nouwen J; Op 't Veld M; van Suijlekom-Smit LW; van der Wouden JC; Verduin C
J Clin Microbiol; 2003 Jul; 41(7):3017-21. PubMed ID: 12843036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
